{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:18:22Z","timestamp":1778869102473,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.06635"],"award-info":[{"award-number":["2020.06635"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtm.2025.101619","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:27:09Z","timestamp":1761413229000},"page":"101619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SLC20A1 knockout to stably express a fusogenic gibbon ape leukemia virus envelope glycoprotein for lentiviral vector production"],"prefix":"10.1016","volume":"33","author":[{"given":"Rodrigo Jos\u00e9","family":"Nogueira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Alexandre","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-6890","authenticated-orcid":false,"given":"Ana Sofia","family":"Coroadinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101619_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3721","article-title":"Gene therapy clinical trials worldwide to 2023\u2014an update","volume":"26","author":"Ginn","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.omtm.2025.101619_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000017","article-title":"Progress and Perspectives in the Development of Lentiviral Vector Producer Cells","volume":"16","author":"Ferreira","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtm.2025.101619_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/156652310793797748","article-title":"Large-Scale Production Means for the Manufacturing of Lentiviral Vectors","volume":"10","author":"Schweizer","year":"2010","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101619_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.18609\/cgti.2018.109","article-title":"Back to the future: where are we taking lentiviral vector manufacturing?","volume":"4","author":"Lesch","year":"2018","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtm.2025.101619_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coche.2018.09.007","article-title":"Progressing from transient to stable packaging cell lines for continuous production of lentiviral and gammaretroviral vectors","volume":"22","author":"Park","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.omtm.2025.101619_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23593-y","article-title":"LentiPro26: Novel stable cell lines for constitutive lentiviral vector production","volume":"8","author":"Tom\u00e1s","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101619_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-0716-2441-8_16","article-title":"Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy","volume":"2521","author":"Coroadinha","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101619_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbiotec.2016.10.016","article-title":"Challenges of up-scaling lentivirus production and processing","volume":"240","author":"McCarron","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101619_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt815","article-title":"Continuous high-titer HIV-1 vector production","volume":"21","author":"Ikeda","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101619_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.33","article-title":"RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope","volume":"3","author":"Marin","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2012.190","article-title":"RD2-MolPack- Chim3, a Packaging Cell Line for Stable Production of Lentiviral Vectors for Anti-HIV Gene Therapy","volume":"24","author":"Stornaiuolo","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2025.101619_bib15","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1038\/srep09021","article-title":"Construction of stable packaging cell lines for clinical lentiviral vector production","volume":"5","author":"Sanber","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101619_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2019.08.001","article-title":"Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes","volume":"15","author":"Tom\u00e1s","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/hgtb.2017.084","article-title":"Pseudotyped Lentiviral Vectors: One Vector, Many Guises","volume":"28","author":"Joglekar","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2025.101619_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/viro.2000.0394","article-title":"Lentiviral Vectors Pseudotyped with Envelope Glycoproteins Derived from Gibbon Ape Leukemia Virus and Murine Leukemia Virus 10A1","volume":"273","author":"Stitz","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2025.101619_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.gt.3302189","article-title":"Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells","volume":"11","author":"Strang","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101619_bib20","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1128\/jvi.64.11.5270-5276.1990","article-title":"Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity","volume":"64","author":"Page","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101619_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101619_bib22","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/JVI.75.9.4129-4138.2001","article-title":"Sequences in the Cytoplasmic Tail of the Gibbon Ape Leukemia Virus Envelope Protein That Prevent Its Incorporation into Lentivirus Vectors","volume":"75","author":"Christodoulopoulos","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101619_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1258\/ebm.2010.010053","article-title":"RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors","volume":"235","author":"Bell","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.omtm.2025.101619_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/mthe.2002.0549","article-title":"Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood","volume":"5","author":"Hanawa","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101619_bib25","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.15252\/emmm.201708148","article-title":"Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy","volume":"9","author":"Milani","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2025.101619_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.omto.2021.11.012","article-title":"Improved lentiviral vector titers from a multi-gene knockout packaging line","volume":"23","author":"Han","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtm.2025.101619_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtm.2018.11.006","article-title":"CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells","volume":"13","author":"Ozog","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib28","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.91.15.7071","article-title":"Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters","volume":"91","author":"Kavanaugh","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101619_bib29","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2025.101619_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/gt.2015.44","article-title":"Single-step cloning-screening method: A new tool for developing and studying high-titer viral vector producer cells","volume":"22","author":"Rodrigues","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101619_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.omtm.2018.07.013","article-title":"Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes","volume":"10","author":"Tijani","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib32","series-title":"Functional Phosphate Materials and Their Applications","article-title":"Inorganic Phosphate: The Backbone of Life","author":"Mustaev","year":"2023"},{"key":"10.1016\/j.omtm.2025.101619_bib33","doi-asserted-by":"crossref","first-page":"31363","DOI":"10.1074\/jbc.M109.053132","article-title":"Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity","volume":"284","author":"Beck","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101619_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101619_bib35","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1016\/j.celrep.2017.11.100","article-title":"RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a","volume":"21","author":"Sundaresan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101619_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/gt.2016.72","article-title":"Non-viral delivery of genome-editing nucleases for gene therapy","volume":"24","author":"Wang","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101619_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR\/Cas9-Mediated Gene Editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","article-title":"A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing","volume":"12","author":"Li","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101619_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15334","article-title":"Hit and go CAS9 delivered through a lentiviral based self-limiting circuit","volume":"8","author":"Petris","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101619_bib40","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A Third-Generation Lentivirus Vector with a Conditional Packaging System","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101619_bib41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2025.101619_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101619_bib43","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101619_bib44","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1073\/pnas.94.19.10319","article-title":"Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector","volume":"94","author":"Miyoshi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101619_bib45","first-page":"379","article-title":"Analysis of Mutation in Human Cells by Using an Epstein-Barr Virus Shuttle System","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101619_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/biom13030459","article-title":"Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors","volume":"13","author":"Silva","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtm.2025.101619_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:09Z","timestamp":1778867709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2329050125002141"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101619","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC20A1 knockout to stably express a fusogenic gibbon ape leukemia virus envelope glycoprotein for lentiviral vector production","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101619"}}